Our Products

"Valeo Pharma is focused on bringing products to Canadian physicians, providing them with more choice to meet the ever increasing needs of their patients."

- Marc Léger, Executive VP, Commercial Operations

Synacthen® Depot

Valeo Pharma currently markets PrSynacthen® Depot (1mg/mL). Synacthen is a synthetic ACTH product that is used in conditions where the production of natural cortisol and other hormones is desired. There are currently 17 indications for Synacthen approved by Health Canada. These include:

  • Acute exacerbations of Multiple Sclerosis
  • Rheumatoid arthritis
  • Lupus Erythematosus
  • Bell's Palsy
  • Ulcerative Colitis
  • Psoriatic Arthritis
  • Scleroderma
  • Nephrotic Syndrome
  • Adjuvant Treatment in cases of acute gout

For further information please consult the product monograph.

Synacthen® is a registered trademark of Novartis AG and is used under licence by Questcor Operations Ltd.